LAUREN STUDEY: Open Payments
NPI 1922635648 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 19 payments from 12 companies in 2025. Trend: 2023 $415 · 2024 $257 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $74 |
| Blue Earth Diagnostics | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Stemline Therapeutics Inc. | 1 | $27 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $24 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $23 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $20 |
Products named: EPKINLY, POSLUMA, Vyloy, ELZONRIS, ZYNLONTA, PLUVICTO, PYLARIFY, ERLEADA.
Industry payments across TX — which companies pay providers there.
